Sterling Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Sterling Wealth Management's ABBV Position: Q3 2026 in Review
Sterling Wealth Management increased its AbbVie (ABBV) stake by 0.03% in Q3 2026, buying an estimated $256 and bringing the position to 3,036 shares worth $794K. The position accounts for 0.2% of the portfolio, ranked #50.
Sterling Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Sterling Wealth Management held 3,036 shares of AbbVie worth $794K as of Q3 2026.
- Sterling Wealth Management bought 1 AbbVie share in Q3 2026, an estimated $256.
- AbbVie made up 0.2% of Sterling Wealth Management's portfolio in Q3 2026, its #50 holding.
- Sterling Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
- 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Sterling Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.